Cargando…
A POPULATION PHARMACOKINETIC MODELING APPROACH TO EVALUATE THE CURRENT DOSING RECOMMENDATIONS OF FAVIPIRAVIR IN EGYPTIAN SUBJECTS
INTRO: Favipiravir is approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for managing emerging influenza and is under investigation for treating SARS-CoV-2 cases. While favipiravir's pharmacokinetics is similar between healthy and infected subjects, a previous study repo...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186905/ http://dx.doi.org/10.1016/j.ijid.2023.04.234 |